FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 45 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $96,000 | -16.5% | 15,500 | 0.0% | 0.00% | – |
| Q4 2020 | $115,000 | +23.7% | 15,500 | 0.0% | 0.00% | – |
| Q3 2020 | $93,000 | -27.9% | 15,500 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $129,000 | – | 15,500 | – | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2019 | $16,000 | -23.8% | 3,300 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -22.2% | 3,300 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -20.6% | 3,300 | 0.0% | 0.00% | – |
| Q2 2018 | $34,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |